SPORADIC AMYOTROPHIC LATERAL SCLEROSIS
Clinical trials for SPORADIC AMYOTROPHIC LATERAL SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SPORADIC AMYOTROPHIC LATERAL SCLEROSIS trials appear
Sign up with your email to follow new studies for SPORADIC AMYOTROPHIC LATERAL SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ALS drug safety trial launches for Long-Term study
Disease control Recruiting nowThis study tests the long-term safety of a drug called LY4256984, given via spinal injection, in people with ALS. It includes 32 participants who completed an earlier study and will be followed for about 96 weeks. The main goal is to see how many people have serious side effects …
Matched conditions: SPORADIC AMYOTROPHIC LATERAL SCLEROSIS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New ALS drug injected into spine begins human testing
Disease control Recruiting nowThis early-stage study tests a new drug called LY4256984 in 32 people with sporadic ALS. The drug is injected into the spine to see if it is safe and how the body handles it. The main goal is to check for side effects, not yet to prove it works.
Matched conditions: SPORADIC AMYOTROPHIC LATERAL SCLEROSIS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC